0 items USD 0.00Search
Your search for "globaldata chronic myelocytic leukemia cml chronic myeloid leukemia global clinical trials review h1" gave back 763000 results.
The global Tasigna market size was valued at US$ 1881.2 million in 2023. With growing demand in downstream market, the Tasigna is forecast to a...
Catalog:
LPI
March 2024
Price: USD 3,660.00
The global Hairy Cell Leukemia Drugs market size was valued at US$ 160.6 million in 2023. With growing demand in downstream market, the Hairy Cell...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Erwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The Pharmerging market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Medical FLT3 inhibitor is a type of medication that targets and inhibits the activity of the FLT3 receptor, a protein found on the surface of certain...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Erwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Hematologic Malignancies market size was valued at US$ million in 2023. With growing demand in downstream market, the Hematologic...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Erwinase market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Erwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
TASIGNA can be prescribed to treat Philadelphia chromosome-positive chronic myeloid leukemia. The global Tasigna market was valued at US$ 1923...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Erwinase market size was valued at US$ million in 2023. With growing demand in downstream market, the Erwinase is forecast to a readjusted...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Hairy cell leukemia is a slow-growing, rare type of chronic cell leukemia. The global Hairy Cell Leukemia Drugs market was valued at US$ 164.2...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Leukemia Therapeutics market was valued at US$ 10920 million in 2023 and is anticipated to reach US$ 12890 million by 2030, witnessing a...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
